Literature DB >> 28106291

Ocular Effects of Sulfur Mustard and Therapeutic Approaches.

Yunes Panahi1, Seyyed Mahdi Rajaee1, Amirhossein Sahebkar2.   

Abstract

Sulfur mustard (SM) is a strong blistering, highly reactive, lipophilic chemical war agent that causes injury in different organs including the skin, eyes, and respiratory tract. The Eyes are especially susceptible to the consequences of SM poisoning because of the aqueous and mucosal nature of conjunctiva and cornea. DNA alkylation and depletion of glutathione, are the most important mechanisms of SM action in the eye injuries. Acute clinical symptoms are including decrease in visual acuity, dryness, photophobia, blepharospasm, conjunctivitis, and complaints of foreign body sensation and soreness that gradually progress to severe ocular pain. Corneal abrasions, ulcerations, vesication, and perforations are common corneal consequences in SM injured victims. Appearance of chronic symptoms has been reported as chronic inflammation of the corneal and conjunctival vasculature, ischemia, lipid and cholesterol deposition, scarring in cornea, corneal thinning, opacification and perforation of the cornea, limbal stem cell deficiency (LSCD), and neovascularization. Different medical and surgical protocols have been documented in the management of SM-induced ocular injuries, including preservative-free artificial tears, topical steroids and antibiotic, mydriatic, antiglaucoma drops, therapeutic contact lenses, dark glasses and punctal plugs/cauterization, N-acetylcysteine, tarsorrhaphy, amniotic membrane transplantation, stem cell transplantation, and corneal transplantation. New drugs such as resolvin E1, topical form of essential fatty acids, thymosin β4, 43 amino-acid polypeptides, topical form of curcumin, newly formulated artificial tears, diquafosol, rebamipide, tretinoin, and oral uridineseems to be beneficial in the management of ocular lesion associated with sulfur mustard poisoning. Further studies are needed to approve these drugs in SM victims. J. Cell. Biochem. 118: 3549-3560, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  LIMBAL STEM CELL DEFICIENCY; MUSTARD GAS; MUSTARD GAS KERATOPATHY; OCULAR LESION; SULFUR MUSTARD

Mesh:

Substances:

Year:  2017        PMID: 28106291     DOI: 10.1002/jcb.25892

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Characterization of the rabbit conjunctiva: Effects of sulfur mustard.

Authors:  Laurie B Joseph; Marion K Gordon; Jieun Kang; Claire R Croutch; Peihong Zhou; Diane E Heck; Debra L Laskin; Jeffrey D Laskin
Journal:  Exp Mol Pathol       Date:  2021-06-01       Impact factor: 4.401

Review 2.  Synthetic high-density lipoprotein nanoparticles: Good things in small packages.

Authors:  Robert M Lavker; Nihal Kaplan; Kaylin M McMahon; Andrea E Calvert; Stephen E Henrich; Ummiye V Onay; Kurt Q Lu; Han Peng; C Shad Thaxton
Journal:  Ocul Surf       Date:  2021-04-21       Impact factor: 6.268

Review 3.  Ocular toxicity of mustard gas: A concise review.

Authors:  Allison Fuchs; Elizabeth A Giuliano; Nishant R Sinha; Rajiv R Mohan
Journal:  Toxicol Lett       Date:  2021-02-15       Impact factor: 4.271

4.  Pathophysiology and inflammatory biomarkers of sulfur mustard-induced corneal injury in rabbits.

Authors:  Dinesh G Goswami; Neha Mishra; Rama Kant; Chapla Agarwal; Claire R Croutch; Robert W Enzenauer; Mark J Petrash; Neera Tewari-Singh; Rajesh Agarwal
Journal:  PLoS One       Date:  2021-10-12       Impact factor: 3.240

5.  Establishment of the New Zealand white rabbit animal model of fatty keratopathy associated with corneal neovascularization.

Authors:  Yikui Gao; Cong Li; Xiaoyun Li; Minghong Zhang
Journal:  Open Life Sci       Date:  2021-12-03       Impact factor: 0.938

6.  Tear proteomics analysis of patient suffered from delayed mustard gas keratopathy.

Authors:  Shahram Parvin; Alireza Shahriary; Hossein Aghamollaei; B Fatemeh Nobakht M Gh; Hasan Bagheri; Mostafa Ghanei; Seyed-Hashem Daryabari; Khosrow Jadidi; Masoud Arabfard
Journal:  Proteome Sci       Date:  2022-08-10       Impact factor: 2.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.